Your search for oral corticosteroids returned 132 results

Your search for oral corticosteroids returned 132 results

Sort Results:

Relevant Recent
Drugs in the Pipeline

Supplemental NDA submitted for Aerospan for asthma

Acton announced that it has submitted a supplemental New Drug Application (sNDA) to the FDA for its new asthma product, Aerospan (flunisolide HFA, 80 mcg) Inhalation Aerosol.

Aerospan Inhalation Aerosol Approved for Asthma

Acton Pharmaceuticals announced that the FDA has approved the sNDA (Supplemental New Drug Application) for Aerospan (flunisolide HFA, 80mcg) inhalation aerosol, indicated for the maintenance treatment of asthma as a prophylactic therapy in adult and pediatric patients >6 years old.

Flo-Pred approved for asthma

Taro Pharmaceuticals has received FDA approval for Flo-Pred (prednisolone acetate oral suspension), a prescription corticosteroid for the treatment of asthma, certain allergic and dermatologic conditions, and a variety of other indications.

Clinical Challenge: A Burning, Acneiform Facial Eruption

A white 24-year-old female presents with erythematous, papulopustular patches of skin in a muzzle-like distribution surrounding the mouth, chin, and glabellar region. Her history includes a variety of topical antibiotics that were previously successful with complete resolution; however, at present the lesions are persisting despite the treatment.